Clinical Trial Update: Glutamine Supplementation in Critically Ill Patients With Severe Sepsis [NA]

View source ↗

Summary

The trial evaluating glutamine supplementation in critically ill patients with severe sepsis has completed. No results are described in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Glutamine (glutamine)

Snippet

Sponsor: Changi General Hospital | Conditions: Severe Sepsis | NA | Status: COMPLETED